Research Article
Single Nucleotide Polymorphism of Genes Associated with Metabolic Fatty Liver Disease
Table 1
Characteristics of patients in MAFLD cases and controls.
| | Characteristic | MAFLD cases (n = 282) | Controls (n = 282) | value |
| | Gender (male/female) | 145/137 | 142/140 | — | | Age (y) | 47.8 ± 19.1 | 47.7 ± 19.0 | 0.868 | | Weight (kg) | 57.3 ± 10.6 | 55.8 ± 10.0 | 0.004 | | BMI (kg/m2) | 24.83 (18.61–30.47) | 20.12 (18.51–23.80) | 0.018 | | Glycosylated hemoglobin (%) | 5.6 (4.6–8.1) | 5.3 (4.0–6.0) | 0.067 | | ALT (U/L) | 19.0 (7.0–79.0) | 16.0 (5.0–31.0) | 0.090 | | AST (U/L) | 22.0 (10.0–82.0) | 20.0 (17.0–27.0) | 0.053 | | Triglycerides (mmol/L) | 1.79 (0.66–5.38) | 1.09 (0.38–1.60) | 0.048 | | Cholesterol (mmol/L) | 3.31 (1.69–8.33) | 2.82 (0.87–4.78) | 0.749 | | Low-density lipoprotein (mmol/L) | 2.96 (0.99–7.17) | 2.51 (0.19–3.19) | 0.690 |
|
|
